WVE · NASDAQ
Wave Life Sciences (WVE) Stock Price & Fundamentals
Wave Life Sciences (WVE) closed at $793.82 on Oct 9, 2026, down 0.57% from the previous close of $798.34.
Share price, past year
1Y +28.79%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $793.82 |
| Sep 30, 2026 | $812.70 |
| Aug 31, 2026 | $724.75 |
| Jul 31, 2026 | $728.07 |
| Jun 30, 2026 | $698.19 |
| May 29, 2026 | $671.23 |
| Apr 30, 2026 | $671.48 |
| Mar 31, 2026 | $659.47 |
| Feb 27, 2026 | $653.28 |
| Jan 30, 2026 | $603.46 |
| Dec 31, 2025 | $588.84 |
| Nov 28, 2025 | $618.99 |
| Oct 31, 2025 | $650.24 |
Key statistics
- Market cap
- $153.43B
- P/E (TTM)
- —
- EPS (TTM)
- −$1.08
- Revenue (TTM)
- —
- Net income (TTM)
- −$202.47M
- Shares outstanding
- 193.3M
- Dividend yield
- —
- 52-week range
- $579.87 – $818.41
Wave Life Sciences's market cap is $153.43B, based on a share price of $793.82 and 193.3M shares outstanding as of Jun 30, 2026.
Financials
Wave Life Sciences reported revenue of $42.73M for fiscal 2025, down 60.55% from fiscal 2024.
Wave Life Sciences reported a net loss of $204.38M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $42.73M | −60.6% | −$204.38M | −478.3% | −$1.21 | −$188.21M |
| FY2024ended Dec 31, 2024 | $108.30M | −4.4% | −$97.01M | −89.6% | −$0.70 | −$151.96M |
| FY2023ended Dec 31, 2023 | $113.31M | +3,005.1% | −$57.51M | −50.8% | −$0.54 | −$20.55M |
| FY2022ended Dec 31, 2022 | $3.65M | −91.1% | −$161.82M | −4,434.7% | −$2.05 | −$129.14M |
| FY2021ended Dec 31, 2021 | $40.96M | +104.0% | −$122.25M | −298.4% | −$2.36 | −$89.55M |
| FY2020ended Dec 31, 2020 | $20.08M | +25.6% | −$149.91M | −746.7% | −$3.82 | −$117.32M |
| FY2019ended Dec 31, 2019 | $15.98M | +10.9% | −$193.64M | −1,211.5% | −$5.72 | −$192.15M |
| FY2018ended Dec 31, 2018 | $14.41M | +289.2% | −$146.65M | −1,017.4% | −$5.06 | −$32.80M |
| FY2017ended Dec 31, 2017 | $3.70M | +149.4% | −$101.98M | −2,753.2% | −$3.85 | −$102.56M |
| FY2016ended Dec 31, 2016 | $1.49M | — | −$55.66M | −3,748.2% | −$2.44 | −$37.49M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $2.27M | −$69.36M | −$0.34 |
| Q1 FY2026ended Mar 31, 2026 | $38.25M | −$26.09M | −$0.13 |
| Q2 FY2025ended Jun 30, 2025 | $8.70M | −$50.47M | −$0.31 |
| Q1 FY2025ended Mar 31, 2025 | $9.18M | −$46.88M | −$0.29 |
| Q2 FY2024ended Jun 30, 2024 | $19.69M | — | — |
| Q1 FY2024ended Mar 31, 2024 | $12.54M | — | — |
| Q4 FY2023ended Dec 31, 2023 | $29.06M | — | — |
| Q3 FY2023ended Sep 30, 2023 | $49.21M | — | — |
Company profile
- Name
- Wave Life Sciences, Inc.
- Ticker
- WVE
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Pharmaceutical Preparations
- Headquarters
- 733 Concord Avenue, Cambridge, MA 02138
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001631574
Recent SEC filings
- Jul 30, 2026
- Jul 30, 2026
- Jun 26, 2026
- May 18, 2026
- Apr 30, 2026
- Apr 28, 2026
- Apr 28, 2026
- Apr 21, 2026
Frequently asked questions
What is Wave Life Sciences's stock price?
Wave Life Sciences (WVE) closed at $793.82 on Oct 9, 2026, down 0.57% from the previous close of $798.34.
What is Wave Life Sciences's market cap?
Wave Life Sciences's market cap is $153.43B, based on a share price of $793.82 and 193.3M shares outstanding as of Jun 30, 2026.
How much revenue does Wave Life Sciences make?
Wave Life Sciences reported revenue of $42.73M for fiscal 2025, down 60.55% from fiscal 2024.
Does Wave Life Sciences pay a dividend?
Wave Life Sciences's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Wave Life Sciences, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures